Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Lung Cancer Update
Dr. Neil Love
The Stack
Comic Book Club
Europe Calling Podcast
Europe Calling e.V., Maximilian Fries, Amélie Pasmanns
Don't Be Caught Dead
Catherine Ashton
Earth Ancients
Cliff Dunning
HOLOSKY PODCAST
Holosky Podcast
Fjellsportpodden
Fjellsport.no
Cita con Rama - Podcast de Ciencia Ficción
Motor y al Aire
Environment Daily
Ground Report
People Soup
People Soup
PBS Space Time
PBS
שלושה שיודעים Three Who Know
כאן | Kan
Ogami Station
RatedPower
Radiació de fons
Ràdio Palafrugell
Logically Answered
Logically Answered
Relatos 3roticos En Español ORIGINAL
Eric
Strangeology
Strangeology Podcast
Menno en Erwin over de Natuur en Wetenschap
Natuur en Wetenschap door: Prof. Menno Gerkema en Erwin Balkema
TheFluffenhammer's podcast
The Fluffenhammer
Epochentrotter - erzählte Geschichte
Katharina Gedigk und Marvin Gedigk
Democracy Paradox
Justin Kempf
Weather Wisdom
Dave Epstein
Fire Science Show
Wojciech Wegrzynski
Fire Investigation INFOCUS podcast
Scott Kuhlman and Chasity Owens
Energy Frontier: The Wyoming Landscape
School of Energy Resources at the University of Wyoming
Bigfoot Society
Jeremiah Byron
uyfljlhjlkjgghlkjgjklgl
the master
The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus
BZ Group
Meteorology Matters
Rob Jones
The Hospital Finance Podcast
Besler Holdings
The Impact Equation
Rafi Addlestone and Adam Pike
Protrusive Dental Podcast
Jaz Gulati
Ologies with Alie Ward
Alie Ward
Short Wave
NPR
BirdNote Daily
BirdNote
Alô, Ciência?
Alô, Ciência?
Climate Rising
Harvard Business School Business & Environment Initiative
Science
Dr. Neil Love
Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics:Introduction (0:00)Overview of Antibody...
Featuring perspectives from Dr Lyudmila Bazhenova and Dr Corey J Langer, including the following topics: Introduction (0:00)Therapeutic Approaches Targeting HER2 and RET — Dr Bazhenova (9:09)Therapeutic Approaches Target...
Featuring perspectives from Dr Jonathan Goldman and Dr Zofia Piotrowska, including the following topics:Introduction (0:00)Current Management of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) — Dr Goldman (0:...
Featuring an interview with Prof Martin Reck, including the following topics:Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunothera...
Dr Christine L Hann from the Johns Hopkins University School of Medicine in Baltimore, Maryland, and Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding ...
Dr Suresh S Ramalingam and Dr Helena Yu discuss the selection and sequencing of therapy for patients with EGFR mutation-positive non-small cell lung cancer and summarize major advances in the treatment landscape reported...
Dr Natalie Vokes from The University of Texas MD Anderson Cancer Center in Houston discusses recent developments with circulating tumor DNA assays in the management of lung cancer. CME information and select publications...
Dr Hossein Borghaei from Fox Chase Cancer Center in Philadelphia, Pennsylvania, and Dr Anne Chiang from Yale Cancer Center in New Haven, Connecticut, discuss key clinical trial data in the first-line management of ES-SCL...
Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid and Dr Shields from Indiana University School of Medicine in Indianapolis discuss key datasets surrounding first-line and maintenance therapy ...
Dr Justin F Gainor, Dr Corey J Langer and Dr Misty Dawn Shields summarize the treatment landscape and review relevant clinical datasets for patients with lung cancer.CME information and select publications here.
Dr John Heymach from The University of Texas MD Anderson Cancer Center in Houston discusses recent updates on available and novel treatment strategies for HER2-altered non-small cell lung cancer. CME information and se...
Dr Aaron Lisberg from the University of California, Los Angeles, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publ...
Dr Aaron Lisberg from the University of California, Los Angeles discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and select publi...
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of lung cancer. CME information and select publicati...
Dr Stephen V Liu from Georgetown University Hospital in Washington, DC and Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York discuss the role of approved and novel investigational therapies for pat...
Dr Jacob Sands from Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of non-small cell lung cancer. CME information and s...
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies fo...
Prof Marina Garassino, Dr John Heymach, Prof Solange Peters and moderator Dr Jacob Sands present key data from the ASCO 2025 Annual Meeting on the management of metastatic NSCLC without targetable mutations, as well as e...
Dr Anne Chiang, Dr Erin Schenk, and nurse practitioners Ms Elizabeth Krueger and Ms Beth Sandy discuss the role of bispecific antibodies in the management of small cell lung cancer and strategies to mitigate and manage t...
Prof Nicolas Girard, Dr Jonathan Goldman, Dr Pasi Jänne, Dr Suresh Ramalingam, Dr Joshua Sabari and moderator Dr Helena Yu present data informing treatment decision-making for EGFR-mutated NSCLC at the 2025 ASCO annual m...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.